|
FY2025
12 months to Jan 3, 2026
|
FY2024
12 months to Dec 28, 2024
|
FY2023
12 months to Dec 30, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Jan 1, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash (used in) provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Stock-based compensation | |||||
| Inventory obsolescence write off | |||||
| Loss on impairment of strategic investment asset | |||||
| Loss on disposal and impairment of leased assets | |||||
| Deferred income taxes | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Income taxes | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Customer prepayments | |||||
| Accrued compensation and benefits | |||||
| Other taxes and withholding | |||||
| Other accruals and liabilities | |||||
| Net cash (used in) provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of property and equipment | |||||
| Proceeds from sales of property and equipment | |||||
| Issuance of notes receivable | |||||
| Payment to secure contractual rights | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Net increase (decrease) in short-term borrowings | |||||
| Repurchases of common stock | |||||
| Proceeds from issuance of common stock | |||||
| Debt issuance costs | |||||
| Net cash provided by (used in) financing activities | |||||
| Net (decrease) increase in cash and cash equivalents | |||||
| Cash and cash equivalents, at beginning of period | |||||
| Cash and cash equivalents, at end of period | |||||
| Supplemental Disclosure of Cash Flow Information | |||||
| Income taxes paid, net of refunds | |||||
| Interest paid | |||||
| Purchases of property and equipment included in accounts payable | |||||
Loading...
